Empery Asset Management, LP reports

Company location: New York, NY
Fiscal year end: 31 December

Empery Asset Management, LP has filed 470 SEC EDGAR filings since 31 Jul 2009

SEC filing history

Showing 326-350 of 467 matching filings.

Per page

25

Current page

14

SC 13G/A

EMPERY ASSET MANAGEMENT, LP

Filing date: 16 Jan 2018
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G

AMPLIPHI BIOSCIENCES CORPORATION

Filing date: 16 Jan 2018
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

SC 13G/A filing

Filing date: 16 Jan 2018
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

EYEGATE PHARMACEUTICALS, INC.

Filing date: 16 Jan 2018
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

EMPERY ASSET MANAGEMENT, LP

Filing date: 16 Jan 2018
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

EMPERY ASSET MANAGEMENT, LP

Filing date: 16 Jan 2018
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

METASTAT, INC.

Filing date: 12 Jan 2018
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

ENER-CORE, INC.

Filing date: 12 Jan 2018
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G

INPIXON

Filing date: 12 Jan 2018
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

GREAT BASIN SCIENTIFIC, INC.

Filing date: 12 Jan 2018
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

SOCIAL REALITY, INC.

Filing date: 12 Jan 2018
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

VISTAGEN THERAPEUTICS, INC.

Filing date: 12 Jan 2018
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

INTERPACE DIAGNOSTICS GROUP, INC.

Filing date: 12 Jan 2018
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G

HELIOS & MATHESON ANALYTICS INC.

Filing date: 19 Dec 2017
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G

MYOMO, INC.

Filing date: 04 Dec 2017
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G

SENESTECH, INC.

Filing date: 22 Nov 2017
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G

ELEVEN BIOTHERAPEUTICS, INC.

Filing date: 08 Nov 2017
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G

ATOSSA GENETICS INC.

Filing date: 31 Oct 2017
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G

EMPERY ASSET MANAGEMENT, LP

Filing date: 20 Oct 2017
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G

DIGITAL ALLY, INC.

Filing date: 25 Aug 2017
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G

EMPERY ASSET MANAGEMENT, LP

Filing date: 01 Aug 2017
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G

IMMUNOCELLULAR THERAPEUTICS, LTD.

Filing date: 19 Jul 2017
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G

OPGEN, INC.

Filing date: 18 Jul 2017
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G

EMPERY ASSET MANAGEMENT, LP

Filing date: 14 Jun 2017
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G

BIOPHARMX CORPORATION

Filing date: 01 May 2017
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .